Argent Biopharma Limited NPV (DI)

(RGT)
Sector: Pharmaceuticals & Biotechnology
15.67p
-0.33p -2.08
Last updated: 09:00:10

Company News Headlines

Date Time Headline Source
31/10/2024 07:00 September 2024 Quarterly Report RNS
25/10/2024 07:13 Dispatch of Annual General Meeting Documents RNS
24/10/2024 07:24 Placing to Raise A$200,000 RNS
15/10/2024 08:56 Holding(s) in Company RNS
15/10/2024 08:54 Director/PDMR Shareholding RNS
09/10/2024 07:00 Refinancing of Convertible Security Agreement RNS
01/10/2024 10:33 Result of Meeting RNS
30/09/2024 09:34 Annual Report for the year ended 30 June 2024 RNS
25/09/2024 07:50 Date of AGM & Closing Date of Director Nominations RNS
23/09/2024 07:24 ASX Delisting Update RNS
12/09/2024 07:00 Director/PDMR Shareholding RNS
06/09/2024 07:00 Company Presentation RNS
30/08/2024 07:10 30 June 2024 Preliminary Financial Report RNS
27/08/2024 07:05 Letter from the CEO RNS
27/08/2024 07:00 Notice of General Meeting RNS
21/08/2024 07:00 SINTEF Collaboration for Chronic Wound Management RNS
15/08/2024 07:20 Voluntary Delisting From ASX RNS
30/07/2024 08:00 June 2024 Quarter Activity Report and Cash Flow RNS
16/07/2024 09:58 Placing to Raise US$2,000,000 RNS
01/07/2024 07:02 Company Presentation RNS
01/07/2024 07:00 Placing to Raise US$500,000 RNS
21/06/2024 07:00 Appointment of UK Corporate Broker RNS
23/05/2024 08:00 Change of OTCQB Company Code RNS
07/05/2024 07:00 Trading on the OTCQB and Appointment of CFO RNS
30/04/2024 16:01 PDMR Notification RNS
30/04/2024 08:54 March 2024 Quarter Activity Report RNS
15/04/2024 07:00 Dr. Shlomo Sadoun Joins Advisory Board RNS
10/04/2024 16:30 PDMR Notification RNS